Risdiplam (Evrysdi)

risdiplam · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Risdiplam (Evrysdi), covering 2024-03-05 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) [Phase 4]